FDA.reportPublic FDA data

nevirapine 50 MG in 5 mL Oral Suspension

RxCUI
311943
RxNorm name
nevirapine 50 MG in 5 mL Oral Suspension
Display name
nevirapine 50 MG in 5 mL Oral Suspension
Full name
nevirapine 50 MG in 5 mL Oral Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NevirapineNEVIRAPINEAurobindo Pharma Limited8dfe86aa-ea5d-48d2-94a8-1a5506055d702024-09-04Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 311943

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
8dfe86aa-ea5d-48d2-94a8-1a5506055d70nevirapine 50 MG in 5 mL Oral Suspension [PSN] · nevirapine 10 MG/ML Oral Suspension [SCD] · nevirapine (as nevirapine hemihydrate) 10 MG/ML Oral Suspension [SY] · nevirapine 50 MG per 5 ML Oral Suspension [SY]412These highlights do not include all the information needed to use NEVIRAPINE ORAL SUSPENSION safely and effectively. See full prescribing information for NEVIRAPINE ORAL SUSPENSION. NEVIRAPINE oral suspension Initial U.S. Approval: 199620240904